Digital pathology startup Deep Lens rakes in $3.2 mln seed
Deep Lens Inc, a digital pathology startup, has secured $3.2 million in seed financing. Sierra Ventures led the round with participation from Rev1 Ventures and Tamarind Hill Fund. In conjunction with the financing, Mark Shary, managing member of Tamarind Hill, and Dr. Jeff Elton, CEO of Concerto Health AI, will join the Deep Lens board of directors.
15 October 2018•1 min read
